Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience
Abstract Background Vancomycin treatment of complicated Gram-positive infections is associated with laboratory monitoring, nephrotoxicity, and multiple daily dosing. Oritavancin, a lipoglycopeptide antibiotic with a once-weekly dosing strategy and similar but slightly broader spectrum of activity, p...
Uloženo v:
Hlavní autoři: | , , , , , , |
---|---|
Médium: | Kniha |
Vydáno: |
Adis, Springer Healthcare,
2020-06-01T00:00:00Z.
|
Témata: | |
On-line přístup: | Connect to this object online. |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Jednotka 1 | Dostupné |